Topic List : Transplantation
Heart recipient who gave birth looks back
Just 28 when she received a new heart at Stanford Hospital in 1991, Yolanda Ishaq went on to become the first heart transplant recipient to have a child at Stanford.
Team seeks to decipher vulnerability to virus
Stanford researchers have joined forces to learn how immune cells in some kidney transplant patients fight a common virus. The work could lead to a test to predict who is at risk, and possibly develop new treatments.
One liver donor benefits two patients
Noah Hernandez, born in 2017, and James Howell, born in 1955, each benefited from a single liver to treat their life-threatening conditions.
Tough transplant cases? Hospital up to the task
Dane Conrads, now almost 4, was “desperately ill” when he received his liver transplant in 2014. Last year, he also benefited from one of the most complicated kidney transplants ever performed at Packard Children’s Hospital.
Iron triggers lung transplant infection
Iron enables a common mold to take root in lung transplant recipients, according to Stanford researchers who led a study that offers a new perspective for understanding and treating these pulmonary infections.
50th-anniversary celebration of heart transplant
The landmark heart transplant performed at Stanford in 1968 ultimately led to the success of the operation around the world today.
Landmark heart surgery changed history
On Jan. 6, 1968, as Stanford surgeon Norman Shumway performed the first U.S. adult heart transplantation, the world held its breath.
Siblings get double-lung transplants
David Diaz, 9, who has cystic fibrosis, received a pair of new lungs three years after his sister, who also has CF, underwent a double-lung transplantation.
Samuel Strober awarded $6.6 million
The California Institute for Regenerative Medicine awarded Samuel Strober, MD, $6.6 million to study a “deceptively simple” way to help kidney transplant recipients tolerate their new organ.
Dietary approach to depleting stem cells
A new study shows that a diet deficient in valine effectively depleted the blood stem cells in mice and made it possible to perform a blood stem cell transplantation on them.